G1 Therapeutics Current Ratio 2016-2024 | GTHX
G1 Therapeutics current ratio from 2016 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-06-30 | $0.09B | $0.04B | 2.48 |
| 2024-03-31 | $0.10B | $0.03B | 2.94 |
| 2023-12-31 | $0.12B | $0.03B | 3.87 |
| 2023-09-30 | $0.13B | $0.03B | 3.75 |
| 2023-06-30 | $0.14B | $0.03B | 4.14 |
| 2023-03-31 | $0.15B | $0.03B | 4.57 |
| 2022-12-31 | $0.18B | $0.04B | 5.04 |
| 2022-09-30 | $0.16B | $0.04B | 4.24 |
| 2022-06-30 | $0.18B | $0.04B | 4.75 |
| 2022-03-31 | $0.21B | $0.04B | 5.96 |
| 2021-12-31 | $0.24B | $0.03B | 8.82 |
| 2021-09-30 | $0.23B | $0.03B | 8.68 |
| 2021-06-30 | $0.27B | $0.03B | 10.36 |
| 2021-03-31 | $0.30B | $0.03B | 11.60 |
| 2020-12-31 | $0.22B | $0.02B | 9.23 |
| 2020-09-30 | $0.25B | $0.03B | 7.45 |
| 2020-06-30 | $0.24B | $0.02B | 10.95 |
| 2020-03-31 | $0.24B | $0.02B | 13.20 |
| 2019-12-31 | $0.27B | $0.02B | 13.71 |
| 2019-09-30 | $0.30B | $0.02B | 14.28 |
| 2019-06-30 | $0.33B | $0.02B | 18.35 |
| 2019-03-31 | $0.35B | $0.01B | 30.21 |
| 2018-12-31 | $0.37B | $0.01B | 29.94 |
| 2018-09-30 | $0.39B | $0.01B | 28.67 |
| 2018-06-30 | $0.19B | $0.01B | 13.57 |
| 2018-03-31 | $0.20B | $0.01B | 15.61 |
| 2017-12-31 | $0.11B | $0.01B | 8.94 |
| 2017-09-30 | $0.12B | $0.01B | 11.42 |
| 2017-06-30 | $0.13B | $0.01B | 12.85 |
| 2017-03-31 | $0.00B | 0.00 | |
| 2016-12-31 | $0.00B | 0.00 | |
| 2016-09-30 | $0.00B | 0.00 | |
| 2016-06-30 | $0.00B | 0.00 | |
| 2015-12-31 | $0.00B | 0.00 | |
